These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16714246

  • 1. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH.
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [Abstract] [Full Text] [Related]

  • 2. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH.
    Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
    [Abstract] [Full Text] [Related]

  • 3. [Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients].
    Hu BC, Chu SL, Wang JG, Wang ZH, Wang GL, Gao PJ, Zhu DL.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 25; 86(16):1144-7. PubMed ID: 16796847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 25; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S, Blohmé G, Sylvén C, Mulec H.
    Nephrol Dial Transplant; 1997 Jun 25; 12 Suppl 2():67-70. PubMed ID: 9269704
    [Abstract] [Full Text] [Related]

  • 12. Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors.
    Yu H, Lin S, Zhang Y, Liu G.
    J Hypertens; 2008 Feb 25; 26(2):251-6. PubMed ID: 18192839
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone synthase (CYP11B2) C-344T polymorphism affects the association of age-related changes of the serum C-reactive protein.
    Oki K, Yamane K, Satoh K, Nakanishi S, Yamamoto H, Kohno N.
    Hypertens Res; 2010 Apr 25; 33(4):326-30. PubMed ID: 20094057
    [Abstract] [Full Text] [Related]

  • 14. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov 25; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul 25; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
    Coto E, Marín R, Alvarez V, Praga M, Fernández Andrade C, Arias M, Poveda R, Vallés M, Galcerán JM, Luño J, Rivera F, Campistol JM.
    Nefrologia; 2005 Jul 25; 25(4):381-6. PubMed ID: 16231503
    [Abstract] [Full Text] [Related]

  • 18. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.
    Jiang X, Sheng HH, Lin G, Li J, Lu XZ, Cheng YL, Huang J, Xiao HS, Zhan YY.
    Chin Med J (Engl); 2007 May 05; 120(9):782-6. PubMed ID: 17531119
    [Abstract] [Full Text] [Related]

  • 19. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A, Amer W, Anwar E, Bashir K.
    Saudi J Kidney Dis Transpl; 2009 May 05; 20(3):429-35. PubMed ID: 19414946
    [Abstract] [Full Text] [Related]

  • 20. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C, Wang YY, Xiao ZX, Wang YP, Zhang QY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug 05; 24(4):428-31. PubMed ID: 17680535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.